Meta-omics characteristics of intestinal microbiota associated to HBeAg seroconversion induced by oral antiviral therapy

Abstract Tenofovir and entecavir are currently designated as the preferred oral antiviral drugs for chronic hepatitis B. However, only less than 40% of patients can achieve HBeAg seroconversion. We aim at investigating the role of intestinal microbiome in HBeAg seroconversion induced by oral antivir...

Full description

Bibliographic Details
Main Authors: Yu-Li Zeng, Lei Qin, Wen-Jun Wei, Hong Cai, Xiao-Fang Yu, Wei Zhang, Xiao-Lu Wu, Xiao-Bin Liu, Wei-Ming Chen, Pan You, Mei-Zhu Hong, Yaming Liu, Xuan Dong, Ben-Chang Shia, Jian-Jun Niu, Jin-Shui Pan
Format: Article
Language:English
Published: Nature Publishing Group 2021-02-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-82939-1